View in EDS HTML Full Text PDF Full Text

BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study.

Saved in:
Bibliographic Details
Title: BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study.
Authors: Dupuis-Girod S; Hospices Civils de Lyon, Hôpital Femme-Mère-Enfants, Service de Génétique et centre de Référence de la maladie de Rendu-Osler, 59 Bd Pinel, Bron 69677, France.; Laboratory Biology of Cancer and Infection, University Grenoble Alpes, Inserm, CEA, Grenoble, France., Decullier E; Hospices Civils de Lyon, Pôle Santé Publique, Lyon, France.; Faculté de médecine, Université Lyon 1, Lyon, France., Rivière S; Service de Médecine Interne A, Centre Hospitalier Universitaire, Montpellier, France., Lavigne C; Service de médecine interne-Immunologie clinique, CHU d'Angers, Angers Cedex 09, France., Grobost V; Service de Médecine Interne CHU Estaing, Clermont-Ferrand University Hospital, Clermont-Ferrand, France., Leguy-Seguin V; Service de Médecine Interne 1, CHU Francois Mitterrand, Dijon, France., Maillard H; Service de Médecine Interne et Immunologie Clinique, CHU Lille, Lille, France., Chinet T; Centre Rendu-Osler, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris, Université de Versailles SQY, Boulogne, France., Fargeton AE; Hospices Civils de Lyon, Hôpital Femme-Mère-Enfants, Centre de Référence de la maladie de Rendu-Osler, Bron, France., Guilhem A; Hospices Civils de Lyon, Hôpital Femme-Mère-Enfants, Service de Génétique et centre de Référence de la maladie de Rendu-Osler, Bron, France., Hermann R; Hospices Civils de Lyon, Hôpital, Service d'ORL, Hôpital E. Herriot, Lyon, France.
Source: Therapeutic advances in hematology [Ther Adv Hematol] 2025 Apr 14; Vol. 16, pp. 20406207241300828. Date of Electronic Publication: 2025 Apr 14 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101549589 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6207 (Print) Linking ISSN: 20406207 NLM ISO Abbreviation: Ther Adv Hematol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2040-6207
DOI:10.1177/20406207241300828